Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor

Molecular and Cellular Biochemistry

Volumn 264, Issue 1-2, 2004, Pages 169-181

  Grzenkowicz Wydra, Jolanta ^a,b   Cisowski, Jarosław ^a   Nakonieczna, Joanna ^b   Zarębski, Adrian ^a   Udilova, Natalia ^c   Nohl, Hans ^c   Józkowicz, Alicja ^a,d   Podhajska, Anna ^b   Dulak, Józef ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenesis; Heme oxygenase 1; Nitric oxide; Reactive oxygen species

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLASMID VECTOR; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; CELL STRAIN 3T3; CELL TYPE; DOWNSTREAM PROCESSING; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEASIBILITY STUDY; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN SYNTHESIS REGULATION; REVIEW; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

EID: 4444272652     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000044386.45054.70     Document Type: Review

References (82)

1. Ware JA, Simons M: Angiogenesis in ischemic heart disease. Nat Med 3: 158-164, 1997
2. Simons M: Therapeutic coronary angiogenesis: A fronte praecipitium a tergo lupi? Am J Physiol Heart Circ Physiol 280: H1923-H1927, 2001
3. Laham RJ, Simons M, Sellke F: Gene transfer for angiogenesis in coronary artery disease. Annu Rev Med 52: 485-502, 2001
4. Francis SC, Raizada MK, Mangi AA, Melo LG, Dzau VJ, Vale PR, Isner JM, Losordo DW, Chao J, Katovich MJ, Berecek KH: Genetic targeting for cardiovascular therapeutics: Are we near the summit or just beginning the climb? Physiol Genomics 7: 79-94, 2001
5. Dulak J, Partyka L, Jozkowicz A, Heba G, Prager M, Neumayer C, Sobhian B, Thurner M, Nanobashvili J, Fuegl A, Ratajska A, Polterauer P, Pachinger O, Weidinger F, Dembinska-Kiec A, Redl H, Huk I: Gene transfer of naked VEGF plasmid induces the formation of microvessels but not mature collaterals in ischemic limb muscles. Eur Surg 34: 105-110, 2002
6. Jozkowicz A, Fugl A, Nanobashvili J, Neumayer C, Dulak J, Valentini D, Funovics P, Polterauer P, Redl H, Huk I: Delivery of high dose VEGF plasmid using fibrin carrier does not influence its angiogenic potency. Int J Artif Organs 26: 161-169, 2003
7. Epstein SE, Fuchs S, Zhou YF, Baffour R, Kornowski R: Therapeutic interventions for enhancing collateral development by administration of growth factors: Basic principles, early results and potential hazards. Cardiovasc Res 49: 532-542, 2001
8. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395, 2000
9. Ferrara N: Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications. Semin Oncol 29: 10-14, 2002
10. Freedman SB, Isner JM: Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 136: 54-71, 2002
11. Koransky ML, Robbins RC, Blau HM: VEGF gene delivery for treatment of ischemic cardiovascular disease. Trends Cardiovasc Med 12: 108-114, 2002
12. Khurana R, Martin JF, Zachary I: Gene therapy for cardiovascular disease: A case for cautious optimism. Hypertension 38: 1210-1216, 2001
13. Rissanen TT, Vajanto I, Yla-Herttuala S: Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic. Eur J Clin Invest 31: 651-666, 2001
14. Kiriakidis S, Andreakos E, Monaco C, Foxwell B, Feldmann M, Paleolog E: VEGF expression in human macrophages is NF-kappaB-dependent: Studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2. J Cell Sci 116: 665-674, 2003
15. Maruyama K, Mori Y, Murasawa S, Masaki H, Takahashi N, Tsutusmi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Shibuya M, Inada M, Matsubara H, Iwasaka T: Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases. J Mol Cell Cardiol 31: 607-617, 1999
16. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM: VEGF gene delivery to muscle: Potential role for vasculogenesis in adults. Mol Cell 2: 549-558, 1998
17. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM: VEGF gene delivery to myocardium: Deleterious effects of unregulated expression. Circulation 102: 898-901, 2000
18. Dulak J, Jozkowicz A: Regulation of vascular endothelial growth factor synthesis by nitric oxide: Facts and controversies. Antioxid Redox Signal 5: 123-132, 2003
19. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999
20. Dulak J, Jozkowicz A, Dembinska-Kiec A, Guevara I, Zdzienicka A, Zmudzinska-Grochot D, Florek I, Wojtowicz A, Szuba A, Cooke JP: Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20: 659-666, 2000
21. Dulak J, Jozkowicz A, Guevara I, Dembinska-Kiec A: Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase-implications for gene therapy in cardiovascular diseases. Pol J Pharmacol 51: 233-241, 1999
22. Dulak J, Jozkowicz A, Dichtl W, Alber H, Schwarzacher SP, Pachinger O, Weidinger F: Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation. Atherosclerosis 159: 325-332, 2001
23. Jozkowicz A, Cooke JP, Guevara I, Huk I, Funovics P, Pachinger O, Weidinger F, Dulak J: Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res 51: 773-783, 2001
24. Dulak J, Jozkowicz A: Nitric oxide and angiogenic activity of endothelial cells: Direct or VEGF-dependent effect? Cardiovasc Res 56: 487-488, 2002
25. Frank S, Stallmeyer B, Kampfer H, Schaffner C, Pfeilschifter J: Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells. Biochem J 338 (Pt 2): 367-374, 1999
26. Frank S, Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J: Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J 13: 2002-2014, 1999
27. Xiong M, Elson G, Legarda D, Leibovich SJ: Production of vascular endothelial growth factor by murine macrophages: Regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 153: 587-598, 1998
28. Leibovich SJ, Chen JF, Pinhal-Enfield G, Belem PC, Elson G, Rosania A, Ramanathan M, Montesinos C, Jacobson M, Schwarzschild MA, Fink JS, Cronstein B: Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. Am J Pathol 160: 2231-2244, 2002
29. Kimura H, Ogura T, Kurashima, Y, Weisz A, Esumi H: Effects of nitric oxide donors on vascular endothelial growth factor gene induction. Biochem Biophys Res Commun 296: 976-982, 2002
30. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H: Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95: 189-197, 2000
31. Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima, Y, Hashimoto K, D'Acquisto F, Makuuchi M, Esumi H: Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 276: 2292-2298, 2001
32. Zhang R, Wang L, Zhang L, Chen J, Zhu Z, Zhang Z, Chopp M: Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ Res 92: 308-313, 2003
33. Dulak J, Jozkowicz A, Foresti R, Kasza A, Frick M, Huk I, Green CJ, Pachinger O, Weidinger F, Motterlini R: Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 4: 229-240, 2002
34. Jozkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, Dulak J: Heme oxygenase and angiogenic activity of endothelial cells: Stimulation by carbon monoxide, inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 5: 155-162, 2003
35. Kreiser D, Nguyen X, Wong R, Seidman D, Stevenson D, Quan S, Abraham N, Dennery PA: Heme oxygenase-1 modulates fetal growth in the rat. Lab Invest 82: 687-692, 2002
36. Suzuki M, Iso-o N, Takeshita S, Tsukamoto K, Mori I, Sato T, Ohno M, Nagai R, Ishizaka N: Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Biochem Biophys Res Commun 302: 138-143, 2003
37. Ryter SW, Choi AM: Heme oxygenase-1: Molecular mechanisms of gene expression in oxygen- related stress. Antioxid Redox Signal 4: 625-632, 2002
38. Maulik N: Redox signaling of angiogenesis. Antioxid Redox Signal 4: 805-815, 2002
39. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 271: 21793-21797, 1996
40. Sen CK, Khanna S, Venojarvi M, Trikha P, Ellison EC, Hunt TK, Roy S: Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol 282: H1821-H1827, 2002
41. Sen CK, Khanna S, Babior BM, Hunt TK, Ellison EC, Roy S: Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J Biol Chem 277: 33284-33290, 2002
42. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, Yeo KT, Adamis AP: Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 98: 1667-1675, 1996
43. 2 in rat heart endothelial cells. Free Radic Biol Med 25: 891-897, 1998
44. Castilla MA, Caramelo C, Gazapo RM, Martin O, Gonzalez-Pacheco FR, Tejedor A, Bragado R, Arroyo MV: Role of vascular endothelial growth factor (VEGF) in endothelial cell protection against cytotoxic agents. Life Sci 67: 1003-1013, 2000
45. Ruef J, Hu ZY, Yin LY, Wu Y, Hanson SR, Kelly AB, Harker LA, Rao GN, Runge MS, Patterson C: Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res 81: 24-33, 1997
46. Kosmidou I, Xagorari A, Roussos C, Papapetropoulos A: Reactive oxygen species stimulate VEGF production from C(2)C(12) skeletal myotubes through a PI3K/Akt pathway. Am J Physiol Lung Cell Mol Physiol 280: L585-L592, 2001
47. Cho M, Hunt TK, Hussain MZ: Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release. Am J Physiol Heart Circ Physiol 280: H2357-H2363, 2001
48. Zelko IN, Mariani TJ, Folz RJ: Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1,) Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33: 337-349, 2002
49. Aebi H: Catalase in vitro. Methods Enzymol 105: 121-126, 1984
50. Flohe L, Otting F: Superoxide dismutase assays. Methods Enzymol 105: 93-104, 1984.
51. Beauchamp C, Fridovich I: Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem 44: 276-287, 1971
52. Tarpey MM, Fridovich I: Methods of detection of vascular reactive species: Nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 89: 224-236, 2001
53. Krzesz R, Wagner AH, Cattaruzza M, Hecker M: Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activation of transcription-1. FEBS Lett 453: 191-196, 1999
54. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991
55. Michiels C, Minet E, Mottet D, Raes M: Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes. Free Radic Biol Med 33: 1231-1242, 2002
56. Ammendola R, Mesuraca M, Russo T, Cimino F: The DNA-binding efficiency of Sp1 is affected by redox changes. Eur J Biochem 225: 483-489, 1994
57. Semenza GL: HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13: 167-171, 2001
58. 2- in vascular smooth muscle cells. Circ Res 77: 29-36, 1995
59. Fridovich I: Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J Biol Chem 245: 4053-4057, 1970
60. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF: Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89: 2183-2189, 1994
61. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E: Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis. Cardiovasc Res 28: 1176-1179, 1994
62. Richard DE, Berra E, Pouyssegur J: Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275: 26765-26771, 2000
63. Page EL, Robitaille GA, Pouyssegur J, Richard DE: Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem 277: 48403-48409, 2002
64. Bassus S, Herkert O, Kronemann N, Gorlach A, Bremerich D, Kirchmaier CM, Busse R, Schini-Kerth VB: Thrombin causes vascular endothelial growth factor expression in vascular smooth muscle cells: Role of reactive oxygen species. Arterioscler Thromb Vasc Biol 21: 1550-1555, 2001
65. Brandes RP, Miller FJ, Beer S, Haendeler J, Hoffmann J, Ha T, Holland SM, Gorlach A, Busse R: The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. Free Radic Biol Med 32: 1116-1122, 2002
66. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, Busse R: Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res 89: 47-54, 2001
67. Gao N, Jiang BH, Leonard SS, Corum L, Zhang Z, Roberts JR, Antonini J, Zheng JZ, Flynn DC, Castranova V, Shi X: P38 Signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J Biol Chem 277: 45041-45048, 2002
68. Gao N, Ding M, Zheng JZ, Zhang Z, Leonard SS, Liu KJ, Shi X, Jiang BH: Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J Biol Chem 277: 31963-31971, 2002
69. Milanini-Mongiat J, Pouyssegur J, Pages G: Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: Their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277: 20631-20639, 2002
70. Maxwell PH, Ratcliffe PJ: Oxygen sensors and angiogenesis. Semin Cell Dev Biol 13: 29-37, 2002
71. Kim HH, Lee SE, Chung WJ, Choi Y, Kwack K, Kim SW, Kim MS, Park H, Lee ZH: Stabilization of hypoxia-inducible factor-1alpha is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells. Cytokine 17: 14-27, 2002
72. Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, Brown LF, Cohen C, Moses M, Kilroy S, Arnold RS, Lambeth JD: Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci USA 99: 715-720, 2002
73. Zhou W, Zhang Y, Hosch MS, Lang A, Zwacka RM, Engelhardt JF: Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion. Hepatology 33: 902-914, 2001
74. Zwacka RM, Zhou W, Zhang Y, Darby CJ, Dudus L, Halldorson J, Oberley L, Engelhardt JF: Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. Nat Med 4: 698-704, 1998
75. Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB: Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem 273: 13245-13254, 1998
76. Wenk J, Brenneisen P, Wlaschek M, Poswig A, Briviba K, Oberley TD, Scharffetter-Kochanek K: Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem 274: 25869-25876, 1999
77. Oberley LW: Anticancer therapy by overexpression of superoxide dismutase. Antioxid Redox Signal 3: 461-472, 2001
78. Huang CY, Fujimura M, Chang YY, Chan PH: Overexpression of copper-zinc superoxide dismutase attenuates acute activation of activator protein-1 after transient focal cerebral ischemia in mice. Stroke 32: 741-747, 2001
79. Huang CY, Fujimura M, Noshita N, Chang YY, Chan PH: SOD1 down-regulates NF-kappaB and c-Myc expression in mice after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21: 163-173, 2001
80. Zhang Y, Zhao W, Zhang HJ, Domann FE, Oberley LW: Overexpression of copper-zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res 62: 1205-1212, 2002
81. Kelner MJ, Uglik SF: Superoxide dismutase abolishes the platelet-derived growth factor-induced release of prostaglandin E2 by blocking induction of nitric oxide synthase: Role of superoxide. Arch Biochem Biophys 322: 31-38, 1995
82. Marikovsky M, Nevo N, Vadai E, Harris-Cerruti C: Cu/Zn superoxide dismutase plays a role in angiogenesis. Int J Cancer 97: 34-41, 2002